The Role of GST Gene Polymorphic Variants in Antipsychotic-Induced Metabolic Disorders in Schizophrenia: A Pilot Study
The life expectancy of patients with psychotic disorders is significantly shorter than that of the general population; antipsychotic-induced metabolic disorders play a significant role in reducing life expectancy. Both metabolic syndrome (MetS) and schizophrenia are multifactorial conditions. One ar...
Saved in:
Main Authors: | Irina A. Mednova, Ekaterina V. Mikhalitskaya, Natalia M. Vyalova, Diana Z. Paderina, Dmitry A. Petkun, Vladimir V. Tiguntsev, Elena G. Kornetova, Nikolay A. Bokhan, Svetlana A. Ivanova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/18/7/941 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polymorphic variants of xenobiotic metabolism genes and body mass index in schizophrenia patients receiving antipsychotic therapy
by: I. V. Pozhidaev, et al.
Published: (2019-12-01) -
Polymorphic variant of <i>NQO1</i> rs1800566 and antipsychotic-induced metabolic disorders in patients with schizophrenia
by: V. V. Tiguntsev, et al.
Published: (2025-07-01) -
Somatotype and morphological characteristics of metabolic syndrome in patients with schizophrenia and persons without mental disorders
by: E. G. Kornetova, et al.
Published: (2023-04-01) -
THE COMPARATIVE EFFICACY OF PERSONALIZING THERAPY WITH ANTICONVULSANTS AND ANTIPSYCHOTICS ON THE BASIS OF PHARMACOGENETIC TESTING
by: T. V. Dokukina, et al.
Published: (2016-08-01) -
Sexual differences in the clinical features of antipsychotic-induced hyperprolactinemia in patients with schizophrenia
by: E. G. Kornetova, et al.
Published: (2019-10-01)